- Home
- LIXT vs SGD Comparison
LIXT vs SGD Comparison
Compare LIXT & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- SGD
- Stock Information
- Founded
- LIXT 2005
- SGD 2021
- Country
- LIXT United States
- SGD United States
- Employees
- LIXT N/A
- SGD N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- LIXT Health Care
- SGD
- Exchange
- LIXT Nasdaq
- SGD Nasdaq
- Market Cap
- LIXT 4.1M
- SGD 3.4M
- IPO Year
- LIXT N/A
- SGD N/A
- Fundamental
- Price
- LIXT $1.93
- SGD $2.22
- Analyst Decision
- LIXT
- SGD
- Analyst Count
- LIXT 0
- SGD 0
- Target Price
- LIXT N/A
- SGD N/A
- AVG Volume (30 Days)
- LIXT 33.2K
- SGD 127.8K
- Earning Date
- LIXT 11-12-2024
- SGD 01-01-0001
- Dividend Yield
- LIXT N/A
- SGD N/A
- EPS Growth
- LIXT N/A
- SGD N/A
- EPS
- LIXT N/A
- SGD N/A
- Revenue
- LIXT N/A
- SGD $173,188.00
- Revenue This Year
- LIXT N/A
- SGD N/A
- Revenue Next Year
- LIXT N/A
- SGD N/A
- P/E Ratio
- LIXT N/A
- SGD N/A
- Revenue Growth
- LIXT N/A
- SGD N/A
- 52 Week Low
- LIXT $1.31
- SGD $1.45
- 52 Week High
- LIXT $4.40
- SGD $53.80
- Technical
- Relative Strength Index (RSI)
- LIXT 57.92
- SGD 40.85
- Support Level
- LIXT $1.85
- SGD $2.05
- Resistance Level
- LIXT $2.65
- SGD $2.40
- Average True Range (ATR)
- LIXT 0.18
- SGD 0.24
- MACD
- LIXT 0.03
- SGD 0.05
- Stochastic Oscillator
- LIXT 43.37
- SGD 26.32
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.